{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:45:31Z","timestamp":1760237131593,"version":"build-2065373602"},"reference-count":18,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the National Research Foundation of Korea (NRF)","award":["2017R1A2A1A17069782"],"award-info":[{"award-number":["2017R1A2A1A17069782"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Hepatitis C virus (HCV) infects ~71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in &gt;95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5\u20138, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.<\/jats:p>","DOI":"10.3390\/v12030302","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T04:13:57Z","timestamp":1583986437000},"page":"302","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6308-9503","authenticated-orcid":false,"given":"Eui-Cheol","family":"Shin","sequence":"first","affiliation":[{"name":"Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Won","family":"Han","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9578-8424","authenticated-orcid":false,"given":"Wonseok","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanobu","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Jun","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon 34114, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Unit of Viral Hepatitis, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai 200031, China"},{"name":"University of Chinese Academy of Sciences, Beijing 100049, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungtaek","family":"Kim","sequence":"additional","affiliation":[{"name":"Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyung","family":"Park","sequence":"additional","affiliation":[{"name":"Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5780-9607","authenticated-orcid":false,"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary\u2019s Hospital, The Catholic University of Korea, Seoul 06591, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Watashi","sequence":"additional","affiliation":[{"name":"Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6324-2224","authenticated-orcid":false,"given":"Jun Yong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc P.","family":"Windisch","sequence":"additional","affiliation":[{"name":"Applied Molecular Virology Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8851-234X","authenticated-orcid":false,"given":"Jong-Won","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Yonsei University, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaji","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3960-6539","authenticated-orcid":false,"given":"Kwang-Hyub","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University College of Medicine, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Key","family":"Jang","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(19)32320-7","article-title":"Hepatitis C","volume":"394","author":"Spearman","year":"2019","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2018.11.010","article-title":"Evolutionary biology of human hepatitis viruses","volume":"70","author":"Rasche","year":"2019","journal-title":"J. Hepatol."},{"doi-asserted-by":"crossref","unstructured":"Ninio, L., Nissani, A., Meirson, T., Domovitz, T., Genna, A., Twafra, S., Srikanth, K.D., Dabour, R., Avraham, E., and Davidovich, A. (2019). Hepatitis C virus enhances the invasiveness of hepatocellular carcinoma via EGFR-mediated invadopodia formation and activation. Cells, 8.","key":"ref_3","DOI":"10.3390\/cells8111395"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1073\/pnas.1822002116","article-title":"Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations","volume":"116","author":"Prentoe","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"doi-asserted-by":"crossref","unstructured":"Kalemera, M., Mincheva, D., Grove, J., and Illingworth, C.J.R. (2019). Building a mechanistic mathematical model of hepatitis C virus entry. PLoS Comput. Biol., 15.","key":"ref_6","DOI":"10.1371\/journal.pcbi.1006905"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2018.11.012","article-title":"SEC14L2, a lipid-binding protein, regulates HCV replication in culture with inter- and intra-genotype variations","volume":"70","author":"Costa","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1074\/jbc.RA118.004397","article-title":"Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation","volume":"294","author":"Kitab","year":"2019","journal-title":"J. Biol. Chem."},{"doi-asserted-by":"crossref","unstructured":"Lassen, S., Gruttner, C., Nguyen-Dinh, V., and Herker, E. (2019). Perilipin-2 is critical for efficient lipoprotein and hepatitis C virus particle production. J. Cell Sci., 132.","key":"ref_9","DOI":"10.1242\/jcs.217042"},{"doi-asserted-by":"crossref","unstructured":"Gerresheim, G.K., Roeb, E., Michel, A.M., and Niepmann, M. (2019). Hepatitis C virus downregulates core subunits of oxidative phosphorylation, reminiscent of the Warburg effect in cancer cells. Cells, 8.","key":"ref_10","DOI":"10.3390\/cells8111410"},{"doi-asserted-by":"crossref","unstructured":"Nguyen, L.P., Tran, S.C., Suetsugu, S., Lim, Y.S., and Hwang, S.B. (2019). PACSIN2 interacts with nonstructural 5A protein and regulates hepatitis C virus assembly. J. Virol.","key":"ref_11","DOI":"10.1128\/JVI.01531-19"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/infdis\/jiz291","article-title":"Dynamic changes in ex vivo T-cell function after viral clearance in chronic HCV infection","volume":"220","author":"Han","year":"2019","journal-title":"J. Infect. Dis."},{"doi-asserted-by":"crossref","unstructured":"Walker, C.M. (2019). Adaptive immune responses in hepatitis A virus and hepatitis E virus infections. Cold Spring Harb Perspect Med., 9.","key":"ref_13","DOI":"10.1101\/cshperspect.a033472"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.20190669","article-title":"Inherited IL-18BP deficiency in human fulminant viral hepatitis","volume":"216","author":"Belkaya","year":"2019","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2017.11.025","article-title":"Innate-like cytotoxic function of bystander-activated CD8(+) T cells is associated with liver injury in acute hepatitis A","volume":"48","author":"Kim","year":"2018","journal-title":"Immunity"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/liv.14014","article-title":"Early HCV viral kinetics under DAAs may optimize duration of therapy in patients with compensated cirrhosis","volume":"39","author":"Gambato","year":"2019","journal-title":"Liver Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jhep.2016.02.022","article-title":"HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir","volume":"64","author":"Dahari","year":"2016","journal-title":"J. Hepatol."},{"doi-asserted-by":"crossref","unstructured":"Canini, L., Imamura, M., Kawakami, Y., Uprichard, S.L., Cotler, S.J., Dahari, H., and Chayama, K. (2017). HCV kinetic and modeling analyses project shorter durations to cure under combined therapy with daclatasvir and asunaprevir in chronic HCV-infected patients. PLoS ONE, 12.","key":"ref_18","DOI":"10.1371\/journal.pone.0187409"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/302\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:06:05Z","timestamp":1760173565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/12\/3\/302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":18,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"alternative-id":["v12030302"],"URL":"https:\/\/doi.org\/10.3390\/v12030302","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2020,3,11]]}}}